News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,476 Results
Type
Article (41996)
Company Profile (436)
Press Release (666044)
Section
Business (208594)
Career Advice (2019)
Deals (35990)
Drug Delivery (102)
Drug Development (83473)
Employer Resources (170)
FDA (16384)
Job Trends (15069)
News (352483)
Policy (33020)
Tag
Academia (2624)
Alliances (50843)
Alzheimer's disease (1360)
Approvals (16358)
Artificial intelligence (217)
Bankruptcy (367)
Best Places to Work (11841)
Biotechnology (330)
Breast cancer (232)
Cancer (1770)
Cardiovascular disease (138)
Career advice (1680)
CAR-T (129)
Cell therapy (379)
Clinical research (67048)
Collaboration (703)
Compensation (379)
COVID-19 (2624)
C-suite (169)
Data (1667)
Diabetes (218)
Diagnostics (6344)
Earnings (86693)
Employer resources (146)
Events (114446)
Executive appointments (586)
FDA (17316)
Funding (631)
Gene therapy (268)
GLP-1 (687)
Government (4446)
Healthcare (19104)
Infectious disease (2740)
Inflammatory bowel disease (130)
Interviews (310)
IPO (16740)
Job creations (3698)
Job search strategy (1432)
Layoffs (467)
Legal (7962)
Lung cancer (260)
Manufacturing (245)
Medical device (13414)
Medtech (13419)
Mergers & acquisitions (19620)
Metabolic disorders (583)
Neuroscience (1798)
NextGen: Class of 2025 (6750)
Non-profit (4545)
Northern California (2137)
Obesity (326)
Opinion (214)
Patents (165)
People (58228)
Phase I (21061)
Phase II (29604)
Phase III (21861)
Pipeline (740)
Postmarket research (2600)
Preclinical (8970)
Radiopharmaceuticals (257)
Rare diseases (345)
Real estate (6005)
Regulatory (22389)
Research institute (2406)
Resumes & cover letters (351)
Southern California (1846)
Startups (3754)
United States (19115)
Vaccines (630)
Weight loss (227)
Date
Today (161)
Last 7 days (720)
Last 30 days (2658)
Last 365 days (35627)
2025 (4756)
2024 (36300)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32186)
2013 (27111)
2012 (29221)
2011 (29863)
2010 (27992)
Location
Africa (734)
Arizona (219)
Asia (38925)
Australia (6478)
California (4933)
Canada (1727)
China (405)
Colorado (223)
Connecticut (243)
Europe (84949)
Florida (701)
Georgia (165)
Illinois (472)
Indiana (262)
Maryland (762)
Massachusetts (3799)
Michigan (200)
Minnesota (341)
New Jersey (1387)
New York (1395)
North Carolina (903)
Northern California (2137)
Ohio (176)
Pennsylvania (1119)
South America (1107)
Southern California (1846)
Texas (719)
Utah (148)
Washington State (488)
708,476 Results for "pliant therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Pliant Stock Crashes After Suspension of Idiopathic Pulmonary Fibrosis Study
It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF study in idiopathic pulmonary fibrosis.
February 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
January 22, 2025
·
6 min read
Business
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
Pliant Therapeutics, Inc., a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, announced the appointment of Steve Krognes to its Board of Directors.
June 13, 2024
·
5 min read
Press Releases
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 7, 2025
·
3 min read
Press Releases
Pliant Therapeutics to Participate in Upcoming Investor Events
November 21, 2024
·
2 min read
Immunology and inflammation
Pliant Brings in Outside Experts to Review IPF Study Pause
The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended suspension of the idiopathic pulmonary fibrosis trial.
February 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Biotech Bay
Pliant Therapeutics to Participate in Upcoming Investor Events - May 1 2024
Pliant Therapeutics, Inc. today announced participation in the following May investor events.
May 1, 2024
·
2 min read
Press Releases
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 14, 2025
·
4 min read
Press Releases
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 22, 2025
January 23, 2025
·
2 min read
1 of 70,848
Next
